Investors and Media
Press Releases
April 17, 2026
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 16, 2026
Scholar Rock to Report First Quarter 2026 Financial Results on May 7, 2026
March 31, 2026
Scholar Rock Resubmits Biologics License Application (BLA) to FDA for Apitegromab for Treatment of Children and Adults with Spinal Muscular Atrophy (SMA)
March 13, 2026
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 3, 2026
Scholar Rock Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
March 3, 2026
CORRECTING and REPLACING Scholar Rock Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
February 18, 2026
Scholar Rock to Present at Upcoming Investor Conferences
February 13, 2026
